Medicure, Inc. (NASDAQ:MCUJF)

BRIEF

published on 11/26/2024 at 00:05, 25 days 18 hours ago

Medicure Announces Q3 2024 Financial Results

Q3 2024 Earnings Medicure Financials Marley Drug Revenues AGGRASTAT Sales Pharmaceutical Competition
PRESS RELEASE

published on 11/26/2024 at 00:00, 25 days 18 hours ago

Medicure Reports Financial Results For Quarter Ended September 30, 2024
Medicure Inc. reports Q3 2024 financial results, including increased revenue from Marley Drug and ZYPITAMAG sales

Financial Results Medicure Inc. Marley Drug Q3 2024 ZYPITAMAG
BRIEF

published on 11/18/2024 at 23:05, 1 month 2 days ago

Medicure to Present Q3 2024 Financial Results Amid Board Changes

Financial Results Conference Call Q3 2024 Board Resignation Medicure
PRESS RELEASE

published on 11/18/2024 at 23:00, 1 month 2 days ago

Medicure to Present Financial Results on November 26, 2024 Call at 8:30 AM ET for Quarter Ended September 30, 2024 and Announces Resignation of Board Member
Medicure Inc. announces 2024 Q3 Financial Results conference call on November 26, 2024. Board member resigns. Company specializes in pharmaceuticals & healthcare products

Conference Call Pharmaceuticals Medicure Inc. Healthcare Products 2024 Q3 Financial Results
BRIEF

published on 10/25/2024 at 00:05, 1 month 27 days ago

Medicure Reaches Settlement in Product Development and Supply Contract

Pharmaceuticals Product Development Healthcare Products Medicure Settlement
PRESS RELEASE

published on 10/25/2024 at 00:00, 1 month 27 days ago

Medicure Announces Positive Settlement of Product Development and Supply Contracts
Medicure Inc. settles a product development and supply contract with a third party, receiving €1.5 million. Details remain confidential. Company focuses on pharmaceuticals and healthcare products in the U.S. market

Pharmaceuticals Medicure Inc. Product Development Healthcare Products Supply Contract
BRIEF

published on 08/14/2024 at 23:35, 4 months 6 days ago

Medicure Completes Acquisition of Intellectual Property from CanAm Bioresearch

Intellectual Property CanAm Bioresearch Medicure Acquisition Therapeutic Development Pharmaceutical Assets
PRESS RELEASE

published on 08/14/2024 at 23:30, 4 months 6 days ago

Medicure Announces Closing of Asset Purchase Agreement with Canam Bioresearch for Acquisition of Intellectual Property
Medicure Inc. acquires intellectual property assets of CanAm Bioresearch Inc. related to new chemical entities for therapeutic use. Agreement terms and related party transaction details provided

Medicure Inc. New Chemical Entities Therapeutic Use CanAm Bioresearch Inc. Intellectual Property Assets
BRIEF

published on 08/14/2024 at 23:05, 4 months 6 days ago

Medicure Reports Financial Results for Quarter Ended June 30, 2024

Financial Results Marley Drug Medicure AGGRASTAT ZYPITAMAG
PRESS RELEASE

published on 08/14/2024 at 23:00, 4 months 6 days ago

Medicure Reports Financial Results for Quarter Ended June 30, 2024
Medicure Inc. reports Q2 2024 financial results: net revenue down, EBITDA negative, net loss recorded. AGGRASTAT and ZYPITAMAG sales impacted. Analyst call on Aug 15, 2024

Financial Results EBITDA Medicure Inc. Net Loss Q2 2024

Published on 12/21/2024 at 01:30, 17 hours 17 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 17 hours 17 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 18 hours 42 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 18 hours 47 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 19 hours 17 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 12/21/2024 at 00:51, 17 hours 56 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 18 hours 2 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 23 hours 36 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 23 hours 51 minutes ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 1 day ago

ARYZTA AG Announces New Board Technology Committee

View all EQS

Published on 12/21/2024 at 12:17, 6 hours 29 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day ago

Disclosure of trading in own shares from 16/12/2024 to 20/12/2024
Published on 12/20/2024 at 14:00, 1 day 4 hours ago

Safran: Woodward Signs Agreement to Acquire Safran’ s Electromechanical Actuation Business based in North America
Published on 12/19/2024 at 18:30, 2 days ago

Share capital decrease by way of treasury shares cancellation

View all LES ECHOS COMFI WIRE

News